What is Nevro Corp.'s current stock price?

Nevro Corp. (NVRO) currently trades at USD 5.84. Track real-time price changes and historical performance on AllInvestView.

What sector is Nevro Corp. in?

Nevro Corp. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Nevro Corp. NVRO · Stock Open Nevro Corp. in new tab

5.84 USD

Add to portfolio

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Nevro Corp. (NVRO)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nevro Corp. Analysis (NVRO)

United States Health Care Official Website Stock

Is Nevro Corp. a good investment? Nevro Corp. (NVRO) is currently trading at 5.84 USD.

Investor FAQ

Does Nevro Corp. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nevro Corp.?

Nevro Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Exchange Ticker

NYQ (United States) NVRO

Trades

No dividend information available for this instrument.

Nevro Corp. NVRO · Stock Open Nevro Corp. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Nevro Corp. Analysis (NVRO)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Nevro Corp. NVRO · Stock Open Nevro Corp. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Nevro Corp. Analysis (NVRO)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications